Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to Various Antibacterial Drugs
- 1 June 1989
- journal article
- research article
- Published by Wiley in Microbiology and Immunology
- Vol. 33 (6) , 509-514
- https://doi.org/10.1111/j.1348-0421.1989.tb02000.x
Abstract
Mycobacterium avium and M. intracellulare of human and natural sources, identified by the Gen‐Probe ®Rapid Diagnostic System for M. avium Complex (MAC) were studied for susceptibility to eight different drugs. In the case of human isolates of MAC, the following was noted. M. avium showed nearly the same susceptibility to streptomycin, kanamycin, ethambutol, and clofazimine as was seen with M. intracellulare. M. avium was much more resistant to rifampicin and rifabutin than was M. intracellulare, and M. avium was more susceptible to quinolones such as ofloxacin and ciprofloxacin. Conversely, in the case of MAC from natural sources, there was no difference between the susceptibility of M. avium and M. intracellulare to these antibacterial agents.This publication has 7 references indexed in Scilit:
- Rapid identification of Mycobacterium avium complex in culture using DNA probesJournal of Clinical Microbiology, 1987
- Rapid identification using a specific DNA probe of Mycobacterium avium complex from patients with acquired immunodeficiency syndromeJournal of Clinical Microbiology, 1987
- Mycobacteria Other than Mycobacterium tuberculosis: Review of Microbiologic and Clinical AspectsClinical Infectious Diseases, 1987
- Disease due to Mycobacterium avium-intracellulareChest, 1985
- Disseminated Mycobacterium avium-intracellulare Infection in Homosexual Men Dying of Acquired ImmunodeficiencyJAMA, 1982
- Treatment of Disease Due to Mycobacterium intracellulareClinical Infectious Diseases, 1981